D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.

@article{Smits2013DcycloserineAO,
  title={D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.},
  author={Jasper A J Smits and Stefan G. Hofmann and David Rosenfield and Lindsey B Deboer and Paul T Costa and Naomi M Simon and Conall O'Cleirigh and Alicia E. Meuret and L. Quintas Marques and Michael W Otto and Mark H. Pollack},
  journal={Journal of consulting and clinical psychology},
  year={2013},
  volume={81 6},
  pages={1100-12}
}
OBJECTIVE The aim of the current study was to identify individual characteristics that (a) predict symptom improvement with group cognitive behavioral therapy (CBT) for social anxiety disorder (SAD; i.e., prognostic variables) or (b) moderate the effects of d-cycloserine (DCS) versus placebo augmentation of CBT for SAD (i.e., prescriptive variables). METHOD Adults with SAD (N = 169) provided Liebowitz Social Anxiety Scale scores in a trial evaluating DCS augmentation of group CBT. Rate of… CONTINUE READING

From This Paper

Topics from this paper.
15 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Similar Papers

Loading similar papers…